30 April 2021 1 Min Read
Risk remains after first Pfizer Covid-19 shot, UK study finds
The immune response after just the first dose was weaker in people who had not previously been infected, leaving them at risk from new variants
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In